Riskpilot← Back to searchSign inGet full accessBIO3 AS
ASActiveOrg 915334504Baseveien 15, 6531 AverøyManufacture of other food products n.e.c. · NACE 1089Est. 20155 employees
Revenue 2024
NOK 2K
EBITDA margin
-98152.1%
-1% vs 2023
Equity ratio
75.2%
Financial strength
Net profit 2024
NOK -1,9M
+6% vs 2023
| Revenue | NOK 2K | — |
| EBITDA | NOK -1,9M | -1% |
| Net profit | NOK -1,9M | +6% |
| Total assets | NOK 33,6M | +219% |
| Equity | NOK 25,3M | +349% |
| Employees | 5 | — |
Legal name
BIO3 AS
Org number
915334504
Legal form
Aksjeselskap
NACE code
1089 · Manufacture of other food products n.e.c.
Founded
5. mai 2015
Share capital
NOK 3 698 318
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Utvikle, produsere og selge biobaserte protein-ingredienser til forindustrien, samt det som naturlig står i forbindelse med dette, herunder deltakelse i andre selskaper.
Address
Baseveien 15, 6531 Averøy
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 65 | 0 | 0 | 0 | 1 251 | 168 | 137 | 0 | 0 | 2 |
| Staff expenses | −152 | −14 | −22 | 26 | −74 | −10 | −4 | −0 | −0 | −335 |
| EBITDA | −253 | −251 | −530 | −712 | 622 | −245 | −198 | −939 | −1 845 | −1 861 |
| Depreciation & amort. | −28 | −42 | −42 | −27 | −19 | −6 | −0 | −0 | −0 | −0 |
| EBIT | −281 | −293 | −572 | −739 | 602 | −252 | −198 | −939 | −1 845 | −1 861 |
| Net financials | −8 | −40 | −67 | −84 | −107 | −140 | −370 | −43 | −135 | 8 |
| Profit before tax | −289 | −333 | −639 | −823 | 495 | −392 | −569 | −982 | −1 980 | −1 853 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −289 | −333 | −639 | −823 | 495 | −392 | −569 | −982 | −1 980 | −1 853 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 677 | 3 334 | 3 350 | 4 186 | 4 277 | 3 970 | 4 026 | 10 636 | 10 522 | 33 597 |
| Equity | 1 711 | 1 678 | 1 039 | 216 | 711 | 319 | −250 | 3 756 | 5 627 | 25 280 |
| Long-term debt | 706 | 1 355 | 2 116 | 2 846 | 3 504 | 3 611 | 3 981 | 3 981 | 3 981 | 4 060 |
| Short-term debt | 260 | 301 | 195 | 1 124 | 63 | 40 | 295 | 2 899 | 914 | 4 257 |
| Total debt | 967 | 1 656 | 2 312 | 3 970 | 3 566 | 3 651 | 4 276 | 6 879 | 4 895 | 8 317 |
EBITDA margin
-98152.1%
This company
15.8%
Market median
-621316% vs market
20152024
Equity ratio
75.2%
This company
38.2%
Market median
+97% vs market
20152024
Return on equity
-7.3%
This company
18.4%
Market median
-140% vs market
20152024
Net profit margin
-97741.4%
This company
8.1%
Market median
-1206784% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20152024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-04-09 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KK Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Sirø Invest As | Company | 66.8% | 66.8% | 2024 |
| Individual | 48.0% | 48.0% | 2022 | |
Hustadlitt A/S | Company | 12.0% | 12.0% | 2024 |
Wenor Engineering As | Company | 10.7% | 10.7% | 2024 |
Awo Consulting As | Company | 8.6% | 8.6% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Atlanticon Bedriftsrådgivning As
BIO3 AS Board members of BIO3 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjartan Kramer | Chief Executive Officer | 0 companies |
| Sigmund Anders Røeggen | Chairman | 0 companies |
| Bjørn Stormer Sørensen | Board of Directors | 0 companies |
| Line Sørensen | Board of Directors | 0 companies |
| Per-Magnus Røeggen | Board of Directors | 0 companies |
| Reidar Eivind Sylthe | Chairman | 0 companies |
| Arne Werner Olsen | Chairman | 0 companies |